Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03164629 · ClinicalTrials.gov registry record · NA
3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization
A NA study of Enlarged Prostate, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03164629: Completed NA study of Enlarged Prostate, sponsored by University of Miami.
NCT03164629 is a NA study of Enlarged Prostate that has completed, run by University of Miami. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03164629, a NA study of Enlarged Prostate, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn about how cone-beam Computerized Tomography scans (X-ray images taken from different angles) work together with an embolization guidance software (helps the doctor see the arteries that feed the prostate)to find and see arteries in the prostate.
Primary Outcome
For the cases using Emboguide this will be measured as the time from which the Emboguide is displayed on the live fluoroscopy to the time of prostatic artery catheterization. Emboguide display is in addition to the angiogram roadmap display. For the control cases this will be measured as the time from which the angiogram is displayed on the live fluoroscopy to the time of prostatic artery catheterization.
Conditions Studied
Interventions
- DEVICE cone-beam CT 3D Emboguide
Study Locations (1)
Florida
- Professional Arts Center - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2018-10-19 |
| Phase | NA |
What the finished NCT03164629 record still lists
NCT03164629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Enlarged Prostate appearing as the primary indexed condition, and to 1 intervention - of which cone-beam CT 3D Emboguide is the first listed.
NCT03164629 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03164629 about?
NCT03164629 is a clinical study titled "3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization". The purpose of this research study is to learn about how cone-beam Computerized Tomography scans (X-ray images taken from different angles) work together with an embolization guidance software (helps the doctor see the arteries that feed the prostate)to find and see arteries in the prostate.
What is the current status of trial NCT03164629?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-04-17. Estimated completion is 2018-10-19.
What conditions does trial NCT03164629 study?
This clinical trial studies the following conditions: Enlarged Prostate.
What interventions are being tested in trial NCT03164629?
The interventions under investigation include: cone-beam CT 3D Emboguide (DEVICE).
Who is sponsoring clinical trial NCT03164629?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03164629 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enlarged Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03164629's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI